GLP-1 and Surgery: What Your Anesthesiologist Needs to Know Before You Go Under

GLP-1 Drugs and Surgery: Should You Stop Ozempic Before Going Under Anesthesia?

Most people planning a surgery think about the obvious stuff — what to eat, when to stop drinking water, which meds to pause. Almost nobody thinks about their Ozempic shot.

New research published in Anesthesia and Analgesia says they should. It turns out GLP-1 drugs like semaglutide and tirzepatide change how your stomach empties food — and that has real implications for anyone heading into surgery.

Important: I'm not a doctor. Everything here is based on published research. Please talk to your physician and your anesthesia team before making any changes to your medication schedule.

---

The Bottom Line

• GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) slow down how fast your stomach empties. This is part of why they reduce appetite — but it can also mean food sits in your stomach longer than expected before surgery.
• Surgeons and anesthesiologists are increasingly using stomach ultrasound to check whether your stomach is actually empty before putting you under — because standard fasting guidelines may not be enough if you're on a GLP-1.
• The decision to pause your GLP-1 before surgery depends on your specific situation: the type of surgery, your dose, how long you've been on it, and your metabolic health.
• If you're scheduled for a procedure requiring general anesthesia, tell your care team you're on a GLP-1 drug before your pre-op appointment. Don't assume they already know.
• This article walks you through the two main options — pause the drug or stay on it — and helps you understand which patients may need which approach.

---

Why This Is a Bigger Deal Than It Sounds

Here's the thing most people don't realize: when you go under general anesthesia, your body's normal protective reflexes — like the ones that prevent you from inhaling stomach contents — are temporarily switched off.

If there's food or liquid still in your stomach, it can travel up into your lungs. Anesthesiologists call this "pulmonary aspiration," and it is a serious, potentially life-threatening complication.

Standard fasting guidelines — typically no food for 6-8 hours, clear liquids up to 2 hours before — were developed based on how quickly a normal stomach empties.

But GLP-1 drugs don't leave your stomach in a "normal" state.

---

What GLP-1 Drugs Actually Do to Your Stomach

GLP-1 receptor agonists work through several mechanisms. One of the most important is delayed gastric emptying — they slow down how fast your stomach moves food into your small intestine.

This is actually a feature, not a bug. Slower emptying means you feel full longer, eat less, and absorb calories more gradually. It's a key reason these drugs work so well for weight loss and blood sugar control.

But that slower emptying doesn't clock out just because surgery is scheduled.

A 2026 study in Anesthesia and Analgesia used gastric ultrasound — a bedside imaging technique — to look at actual stomach contents in patients on GLP-1 drugs right before anesthesia. Even after standard fasting periods, some patients on GLP-1 medications had more stomach content than expected.

That finding matters. A lot.

---

The Two Options: Pause the Drug or Stay on It?

This is the decision most GLP-1 users on the surgical schedule are facing. There's no single right answer — it depends on your situation. Let's break down both sides.

Option 1: Pause Your GLP-1 Before Surgery

This is what many anesthesiology societies are currently recommending as a precaution.

The American Society of Anesthesiologists (ASA) issued guidance suggesting patients on weekly GLP-1 injections consider stopping the drug at least one week before elective surgery. For daily GLP-1 formulations, the suggested pause is at least one day.

The logic is straightforward: give your stomach enough time to return to its normal emptying speed before you go under.

This option makes the most sense if:

• You're having elective (non-emergency) surgery
• Your GLP-1 is primarily for weight loss and can be safely paused for a week or two without serious metabolic consequences
• You don't have tightly controlled type 2 diabetes that requires continuous medication management
• Your surgical team does not have access to gastric ultrasound

The tradeoff: Pausing your GLP-1 may temporarily affect your appetite, blood sugar, and energy levels. You may experience a return of hunger or some blood sugar fluctuation. Most people tolerate a 1-2 week pause without major issues, but your prescribing doctor should know and agree.

---

Option 2: Use Gastric Ultrasound to Check Before Proceeding

This is the newer, more individualized approach — and it's gaining traction in hospitals that have the equipment and training.

Instead of assuming everyone on a GLP-1 has a full stomach, you actually check.

Gastric ultrasound is a quick, non-invasive bedside tool. A clinician places an ultrasound probe on the abdomen and can see how much (if anything) is sitting in the stomach. The 2026 study by Pai et al. used exactly this technique, and it showed that gastric content varied significantly between patients on GLP-1 drugs — not everyone had a dangerously full stomach after fasting.

This matters because blanket "pause all GLP-1s" guidance may be overly conservative for some patients — and potentially harmful if stopping the drug disrupts critical metabolic control.

This option makes the most sense if:

• You have type 2 diabetes and stopping your GLP-1 even briefly risks serious blood sugar swings
• You're at a facility with trained staff and the equipment to perform gastric ultrasound pre-operatively
• Your surgical team wants to make a decision based on actual data rather than blanket protocol
• You're on a lower dose or have recently started a GLP-1 (gastric emptying effects may be less pronounced early in treatment)

The tradeoff: Not every hospital has this capability yet, and interpretation requires trained staff. If your facility doesn't offer it, this option isn't practically available to you.

---

Who Is Most at Risk?

Not all GLP-1 users face equal risk going into surgery. Here's how to think about your specific situation.

Higher concern if you:

• Are on a weekly injectable GLP-1 (like semaglutide/Ozempic or tirzepatide/Mounjaro) at higher doses
• Have been on the drug long enough for full gastroparesis-like effects to develop
• Have pre-existing conditions that already slow stomach emptying (like longstanding type 2 diabetes with autonomic neuropathy)
• Are having upper GI surgery or procedures where stomach contents are especially problematic

Lower concern if you:

• Are on a low dose and early in your GLP-1 journey
• Are having surgery in a region far from the stomach with minimal aspiration risk
• Have confirmed with your team that gastric ultrasound or other assessment will be done pre-op

A recent study comparing GLP-1 receptor agonists to bariatric surgery for patients undergoing subsequent general surgical procedures noted that both weight loss interventions changed surgical risk profiles in meaningful ways — reinforcing why your full medication history matters to the surgical team.

---

What the Stomach Ultrasound Research Actually Found

Let's dig into the actual data from the Pai et al. study for a moment, because this is genuinely interesting.

Researchers looked at patients on GLP-1 drugs who were scheduled for procedures requiring anesthesia. They performed gastric ultrasound to assess stomach content BEFORE the procedure — even after standard fasting.

What they found: a meaningful subset of patients had gastric volumes that would flag as elevated risk, despite following standard fasting guidelines. This is the key finding.

In other words, fasting the standard amount of time doesn't guarantee an empty stomach if you're on a GLP-1. The drug can keep food and fluid in the stomach longer, potentially past the fasting window.

This doesn't mean everyone on a GLP-1 is walking into surgery with a full stomach. But it does mean the standard assumption — "you fasted, you're good" — may not hold.

---

What to Actually Do Before Your Surgery: A Practical Checklist

Here's the actionable part. Whether you're pausing your GLP-1 or staying on it, these steps protect you:

1. Tell your surgical team about your GLP-1 — proactively. Don't wait to be asked. Mention it when you schedule the surgery, at the pre-op appointment, and on your medication form. This includes compounded semaglutide, not just brand-name Ozempic or Wegovy.

2. Ask your prescribing doctor what they recommend. Your endocrinologist or obesity medicine doctor knows your metabolic situation. They can advise whether a short pause is safe for you.

3. Ask your anesthesiologist directly: "Do you use gastric ultrasound for GLP-1 patients?" Not all hospitals do. But more are starting to. If your facility does, it may mean you get an individualized assessment instead of a blanket protocol.

4. If you're told to pause: follow the timeline precisely. If stopping weekly semaglutide, the recommendation is typically at least 7 days before surgery. Not the morning of. Not 3 days before. The full week matters because of semaglutide's long half-life.

5. Don't self-discontinue without medical guidance. Especially if you have type 2 diabetes. Stopping a GLP-1 abruptly without a plan from your doctor can cause blood sugar spikes.

---

The Broader Picture: GLP-1 Drugs Are Changing Surgical Medicine

This isn't just about aspiration risk. The rise of GLP-1 drugs is reshaping how surgeons and anesthesiologists think about patient preparation across the board.

More patients are arriving at the OR after significant weight loss from semaglutide or tirzepatide. Their body composition has changed. Their metabolic risk profiles have shifted. Even research comparing GLP-1 users to bariatric surgery patients shows that both groups experience meaningful changes in surgical risk that require individualized assessment.

The GLP-1 revolution is great news for metabolic health. But it also means that standard protocols built for a different patient population need to evolve. Gastric ultrasound is one tool helping them do that.

---

FAQ

Should I stop Ozempic or Wegovy before surgery? Many anesthesiology guidelines suggest pausing weekly GLP-1 drugs like semaglutide at least one week before elective surgery. But your decision should involve your prescribing doctor and your surgical team, since stopping the drug has its own risks depending on your medical history.

Why do GLP-1 drugs affect anesthesia safety? GLP-1 drugs slow gastric emptying — meaning food and liquid may remain in your stomach longer than usual. Under general anesthesia, a full stomach raises the risk of stomach contents entering the lungs (aspiration), which is a serious complication.

What is gastric ultrasound and why does it matter for GLP-1 users? Gastric ultrasound is a bedside imaging technique that lets clinicians see how much is actually in your stomach before anesthesia. Research published in 2026 shows it can detect elevated stomach content even in patients who fasted as directed — which standard fasting guidelines alone can't confirm.

Does tirzepatide (Mounjaro/Zepbound) carry the same surgery risk as semaglutide? Both are GLP-1 receptor agonists that slow gastric emptying, so the principle applies to both. Tirzepatide also activates GIP receptors, but the gastroparesis-like effect is present with both drugs. Your surgical team should know about any GLP-1 drug you're taking.

Is it always necessary to stop a GLP-1 before surgery? Not necessarily. Facilities with gastric ultrasound capability can assess stomach content directly and make individualized decisions. For patients where stopping the drug poses metabolic risks, an ultrasound-guided approach may be preferable to a blanket pause. Discuss this with your care team.

---

The Bottom Line: What You Should Walk Away With

If you're on a GLP-1 drug and have surgery coming up, you are not automatically at high risk — but you do need to have a specific conversation with your surgical team that most patients aren't having.

The research is clear: standard fasting guidelines were not designed with GLP-1 users in mind. Some patients on these drugs have more stomach content before surgery than expected. Gastric ultrasound is emerging as a practical tool to check, rather than assume.

Your best move today: put "I take [drug name] for weight loss/diabetes" at the top of your pre-op medication list, and ask your anesthesiologist directly how they handle GLP-1 patients.

That one conversation could be the most important thing you do before you go under.

---

Medical Disclaimer: The information on this website is for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide protocol, medication, or supplement regimen. Individual results vary. The author shares personal experience and published research — not medical recommendations.

---

Sources

1. Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia — Anesthesia and Analgesia, 2026
2. GLP-1 Receptor Agonists Versus Bariatric Surgery: Effects of Weight Loss and BMI on Subsequent General Surgical Procedures — Clinical Obesity, 2026
3. The effect of GLP-1 receptor agonists on renal outcomes: a systematic review and meta-analysis — PubMed, 2025
4. Semaglutide and tirzepatide in prediabetes: Evidence for diabetes prevention and cardiovascular protection — Primary Care Diabetes, 2026